Natus Medical Announces Record Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Roth Capital Raises Price Target Following Natus Medical's (BABY) 3Q Results
October 22, 2015 8:20 AM EDTRoth Capital reiterated a Buy rating on Natus Medical (NASDAQ: BABY), and raised the price target to $53.00 (from $51.00), following the company's 3Q15 earnings results. BABY continues to outperform expectations, with 3Q non-GAAP operating margin of 19.9%.
Analyst Chris Lewis commented, "We remain bullish on BABY... More
Natus Medical (BABY) Tops Q3 EPS by 1c
October 21, 2015 6:07 AM EDTNatus Medical (NASDAQ: BABY) reported Q3 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $94.6 million versus the consensus estimate of $93.7 million.
Natus Medical sees Q4 2015 EPS of $0.47-$0.49, versus the consensus of $0.48. Natus Medical sees Q4 2015... More
